Correction: miR-1323 promotes cell migration in lung adenocarcinoma by targeting Cbl-b and is an early prognostic biomarker - Top-Institutions - MDSpire

Correction: miR-1323 promotes cell migration in lung adenocarcinoma by targeting Cbl-b and is an early prognostic biomarker

  • By

  • Huan Zhao

  • Chunlei Zheng

  • Yizhe Wang

  • Kezuo Hou

  • Xianghong Yang

  • Yang Cheng

  • Xiaofang Che

  • Shilin Xie

  • Shuo Wang

  • Tieqiong Zhang

  • Jian Kang

  • Yunpeng Liu

  • Dianzhu Pan

  • Xiujuan Qu

  • Xuejun Hu

  • Yibo Fan

  • July 3, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology

  • #3

    The Cancer Genome Atlas (TCGA)
    The Cancer Genome Atlas (TCGA)

    N/A, N/A

    Key Differentiators

    • Genomics
    • Oncology

  • #4

    Gene Expression Omnibus (GEO)
    Gene Expression Omnibus (GEO)

    N/A, N/A

    Key Differentiators

    • Genomics
    • Bioinformatics

  • #5

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, Massachusetts

    Key Differentiators

    • Oncology

Original Source(s)

Correction: miR-1323 promotes cell migration in lung adenocarcinoma by targeting Cbl-b and is an early prognostic biomarker

  • by Huan Zhao, Chunlei Zheng, Yizhe Wang, Kezuo Hou, Xianghong Yang, Yang Cheng, Xiaofang Che, Shilin Xie, Shuo Wang, Tieqiong Zhang, Jian Kang, Yunpeng Liu, Dianzhu Pan, Xiujuan Qu, Xuejun Hu, Yibo Fan

  • July 3, 2026

Related Content

Quercetagetin-rich flavonoids from marigold induce apoptosis inhibit metastasis of non-small cell lung cancer via the p53/p21 signaling pathway

Hepatic safety of sintilimab versus pembrolizumab in advanced non-small cell lung cancer: a retrospective observational cohort study

Clinicopathological and molecular characteristics of primary pulmonary choriocarcinoma: a case report and systematic review